|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2011-1-13
|
|
pubmed:abstractText |
Invasive fungal infections (IFIs) are an important cause of morbidity and mortality, particularly in patients with cancer. The triazole voriconazole, given as oral or intravenous formulation, has a high bioavailability and proven efficacy against invasive aspergillosis, candidiasis and other fungi. We aimed to assess the utilisation, efficacy and safety of voriconazole with emphasis on the route of administration under standard clinical conditions.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1473-4877
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
335-42
|
|
pubmed:meshHeading |
pubmed-meshheading:21155707-Administration, Oral,
pubmed-meshheading:21155707-Adolescent,
pubmed-meshheading:21155707-Adult,
pubmed-meshheading:21155707-Aged,
pubmed-meshheading:21155707-Aged, 80 and over,
pubmed-meshheading:21155707-Antifungal Agents,
pubmed-meshheading:21155707-Child,
pubmed-meshheading:21155707-Child, Preschool,
pubmed-meshheading:21155707-Critical Illness,
pubmed-meshheading:21155707-Female,
pubmed-meshheading:21155707-Humans,
pubmed-meshheading:21155707-Infant,
pubmed-meshheading:21155707-Injections, Intravenous,
pubmed-meshheading:21155707-Male,
pubmed-meshheading:21155707-Middle Aged,
pubmed-meshheading:21155707-Mycoses,
pubmed-meshheading:21155707-Professional Practice,
pubmed-meshheading:21155707-Prospective Studies,
pubmed-meshheading:21155707-Pyrimidines,
pubmed-meshheading:21155707-Treatment Outcome,
pubmed-meshheading:21155707-Triazoles,
pubmed-meshheading:21155707-Young Adult
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Utilisation, efficacy and safety of voriconazole: prospective, non-interventional study on treatment of IFIs in clinical practice.
|
|
pubmed:affiliation |
Department of Internal Medicine II, Division of Infectious Diseases, University of Wuerzburg Medical Centre, Wuerzburg, Germany. Heinz_w@klinik.uni-wuerzburg.de
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase IV
|
